Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MarketLine (a Datamonitor Company)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories raises FY 2014 EPS outlook

Wednesday, 16 Jul 2014 07:45am EDT 

Abbott Laboratories:Raised FY 2014 ongoing earnings-per-share guidance range to $2.19 to $2.29 from $2.16 to $2.26.Expects FY 2014 GAAP EPS in the range of $1.16 to $1.26.Says guidance for both ongoing and GAAP EPS from continuing operations includes the developed markets branded generics pharmaceuticals business, which is expected to be reported as discontinued operations starting in the Q3 2014.FY 2014 EPS of $2.19 - Thomson Reuters I/B/E/S. 

Company Quote

0.25 +0.51%
28 May 2015